Synergistic induction of apoptosis by combination of BTK and dual mTORC1/2 inhibitors in diffuse large B cell lymphomaScott A. Ezell, Kate F. Byth|Oncotarget|2014Cited by 54
The cellular phenotype of AZ703, a novel selective imidazo[1,2-<i>a</i>]pyridine cyclin-dependent kinase inhibitorKate F. Byth, Andrew P. Thomas|Molecular Cancer Therapeutics|2006Cited by 48